BDX vs TECH
Becton Dickinson and Company (BDX) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the BDX and TECH stock pages for the full models.
Not investment advice.